Advertisement
 
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Accuri Partners With eBioscience

May 11, 2010 8:37 am | News | Comments

Accuri Cytometers, Inc., a life sciences company marketing and producing bench-top flow cytometer systems, and eBioscience, the number two supplier of research flow cytometry reagents, announced that they have entered into a worldwide co-marketing agreement.

TOPICS:

Cytometry Reagents

May 11, 2010 7:49 am | Product Releases | Comments

The Cell Lab Signaling Cytometry (Cell Lab SC) line of reagents from Beckman Coulter, Inc., offers a comprehensive set of antibodies for the detection of the phosphorylation state of signaling proteins in cells via flow cytometry.

TOPICS:

Electronic Document Management

May 11, 2010 7:45 am | Product Releases | Comments

Regulatory compliance experts GxPi announce the availability of its leading Electronic Document Management System (eDMS) x-docs as a hosted software service.

TOPICS:
Advertisement

FDA Accepts Generic Effexor ANDA

May 11, 2010 7:28 am | News | Comments

Intellipharmaceutics International Inc., announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR (venlafaxine hydrochloride).

TOPICS:

Genentech Develops Asthma Antibody

May 11, 2010 7:24 am | News | Comments

Asthma and other allergic diseases are caused by inappropriate immune responses. Soluble IgE molecules, produced by immune cells known as B cells, are key immune mediators of these diseases.

TOPICS:

PPI Associated With Fractures And Infections

May 11, 2010 6:57 am | News | Comments

Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers.

TOPICS:

Gene Mutation Might Determine Proper Dosage

May 11, 2010 6:51 am | News | Comments

A tiny gene mutation in human liver cells could one day influence how high or low a dose patients need of about half of the clinically used drugs on the market, new research suggests.

TOPICS:

Researchers Discover TB Drug Target

May 11, 2010 6:46 am | News | Comments

The cause of tuberculosis is Mycobacterium tuberculosis (Mtb), a slow-growing aerobic bacterium that divides every 16 to 20 hours.

TOPICS:
Advertisement

Cell Signaling May Allow Better Vaccines

May 11, 2010 6:41 am | News | Comments

Inducing cellular immunity as a means to protect against influenza virus is the focus of several laboratories at the Trudeau Institute.

TOPICS:

Merck Settles Zetia Suit

May 11, 2010 6:36 am | News | Comments

Merck & Co. said it settled a patent dispute with Glenmark Pharmaceuticals on the cholesterol drug Zetia, one of its best-selling products.

TOPICS:

Gilead Buying Back $5B of Stock

May 11, 2010 6:32 am | News | Comments

Gilead Sciences, Inc. announced that the company's board of directors has authorized the repurchase of up to $5 billion of the company's common stock through May 2013.

TOPICS:

Abbott Targeting Emerging Markets

May 11, 2010 6:28 am | News | Comments

Abbott Laboratories will license at least 24 products in emerging markets through a new unit created to boost sales outside of the U.S., the drug and medical device maker said.

TOPICS:

Schering-Plough Integration With Merck On Track

May 11, 2010 6:24 am | News | Comments

Drugmaker Merck & Co. said that its integration of Schering Plough Corp. is off to a good start, with sales and other operations already combined in the top 20 companies where they operate.

TOPICS:

HTFC Screening System

May 10, 2010 8:14 am | Product Releases | Comments

IntelliCyt Corp., a provider of innovative high throughput cell and bead-based screening products for drug discovery and life science research, introduced its new High Throughput Flow Cytometry – HTFC Screening System.

TOPICS:

Artel Expands to German-Speaking Countries

May 10, 2010 8:03 am | News | Comments

In a bid to meet growing international demand for its liquid handling quality assurance products and services, Artel is expanding into Germany, Switzerland, and Austria, where it will begin offering direct sales and distribution of its Multichannel Verification System and Pipette Calibration System.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading